We’ve all been touched by cancer.
Cancer is a terrible disease and we all know its devastating impact.   Citizens for Medical Isotopes was founded as a non-profit organization to educate about exciting new cancer treatments that use medical isotopes.   Cell targeting is the wave of the future in treating disease, and because of this ability to specifically target radioisotopes at cancer cells while minimizing exposure to healthy cells, medical isotopes can play an important role in a new revolution in cancer treatment – increased effectiveness, decreased side effects, lives saved, health regained.   But we need your help.


Medical Isotope News
July 9, 2013 Milestones: “Never Give UP” Robert E. Schenter 4-Jan-37 : 9-Jul-13, PhD. With sadness we acknowledge the efforts of “Dr. Bob”. He was a co-founder of Citizens For Medical Isotopes (CMI). Dr. Schenter identified and prepared numerous isotopes using fast reactor technology and prepared a large body of information for CMI. Further information about Dr. Bob can be found at KANDG.ORG.

January 21 , 2010 IsoRay Announces World’s First Cesium-131 Colon Cancer Treatment at Cornell Medical Center Doctors “… at Weill Cornell Medical Center performed the world’s first Cesium-131(Cs-131) implant for the treatment of colorectal cancer” on October 10, 2009.

December 15 , 2009 NRG schedules Petten reactor repairs “Dutch radiopharmaceutical producer Nuclear Research and Consultancy Group (NRG) will begin repairs to the primary cooling water pipework of its High Flux Reactor on February 19, 2010.” (A world supplier of medical isotopes continues offline)

October 26, 2009 CMI Presents at RRMC in San Antonio “21st Century Opportunities To Enhance The Supply And Applications Of Medical Isotopes” Troyer/Schenter/Stevenson Abstract

Dec. 1, 2015 A new FDA approved treatment for prostate cancer called HIFU has recently been released.  Men who are seeking a healthier outcome to traditional surgeries should seek a local urologist to gather additional information.  Prostate cancer symptoms are few and far between and typically requires a patient to undergo a PSA test. Find out which prostate cancers need treatment.

October 21, 2009 Mo-99 supply bill passes House subcommittee
H. R. 3276 To promote the production of molybdenum-99 in the United States for medical isotope production, and to condition and phase out the export of highly enriched uranium for the production of medical isotopes.

October 16, 2009 U.S. Sen. Patty Murray gets $1.25 M for cancer research U.S. Sen. Patty Murray announced that $1.25 million she included for cancer research at Advanced Medical Isotope Corp. of Kennewick has been included in the final version of the fiscal 2010 Senate Energy and Water Development appropriations bill.

September 27, 2009 OSU joins intiative to help with medical isotope shortage Low supplies of radioactive material impacts Salem Oregon Hospital procedures.

September 3 , 2009 Ra-223 targeted for metastesized prostate cancer Bayer AG teams with Algeta of Oslo for worldwide clinical trial of Alpharadin.

August 28, 2009 Isotope costs skyrocket Shortage in wake of Chalk River shutdown leaves hospitals on hook for $750Gs a month.

August 18, 2009 IsoRay Announces FDA Clearance “IsoRay, Inc. (Amex: ISR) announced today that it has received clearance from the FDA for its Premarket Notification, [510(k)] for Proxcelan™ Cesium-131 Brachytherapy Seeds enabling the company to preload Cesium-131 into flexible braided strands and surgical mesh. This FDA clearance allows IsoRay to market Cesium-131 seeds for use in the treatment of cancers well beyond the current prostate market. … “

August 17, 2009 Feds won’t cover PET scans during isotope crisis … Medicare won’t pay for PET bone imaging. And don’t count on insurance companies to bail us out, because they often take their guidance from Medicare policy on which procedures to cover and which to exclude. All of which could make the idea of substituting [accelerator generated F-18] PET bone scans for Tc-99m-based tests a nonstarter for any but the very rich. …

August 15, 2009 Isotope crisis threatens medical care Global production of the feedstock for the leading medical-imaging isotope is low and erratic, putting health care in jeopardy.

August 8, 2009 Isotope shortage means a healthcare crisis The radioisotope is needed to scan for heart disease and cancer. Two nuclear reactors that produce it have been shut down, severely limiting the supply, and alternatives are scant.

July 28, 2009 AAPM: Nanoparticles with radioisotopes developed to treat tumors In a presentation on Tuesday at the 2009 American Association of Physicists in Medicine (AAPM) meeting in Anaheim, Calif., researchers at Johns Hopkins University in Baltimore described the design of nanoparticles that can carry cancer-treating radioisotopes through the body and deliver them to selective tumors. (Also reported in CMI presentation April 5-10.)

April 5-10, 2009 CMI Presents at Eighth International Conference on Methods and Applications of Radioanalytical Chemistry “Medical isotope development and supply opportunities in the 21st century” Troyer/Schenter Abstract

May 17, 2008 Maple reactor development shutdown not without fallout “…The decision has immediate implications: for AECL’s reputation as a seller of reliable nuclear technology sold around the world; for the 2,000-plus people in the Deep River area who work for AECL, and for Nordion’s position as the producer of more than half the world’s isotopes used to diagnose fractures and treat cancers. …”

April 14, 2008 US-DOE Isotope Status Presentation 17-March-2008. Summary:

Insufficient dedicated isotope production capabilities to permit year-round
isotope production.
Aging facilities and equipment.

Isotope research and development needs to be reestablished.
No lead sponsor for large commercial isotopes (americium-241, californium-252).

Batch pricing caused by budget restrictions is impacting research.

Researchers are forced to pay for the entire isotope batch.

No guarantee that research isotopes will be produced when requested.

Reduced isotope portfolio (FY 2002).

March 31, 2008 Tri-City Herald Editorial
Isotope symposium keeps Tri-Cities at the forefront

Mar. 27, 2008 Tri-City Herald News
Advances in isotope science win a surprising convert

On March 26, 2008 – Mini Symposium: The Cure Starts Here!
Citizens for Medical Isotopes is pleased to announce a short symposium featuring regional and national experts in medical isotopes for diagnosis and therapy to be held March 26th at the Three Rivers Convention Center in Kennewick, Washington. Additional Information

Dec. 14, 2007 – CMI staff commentary
A chronology of endorsement and isotope supply needs…

Nov. 20, 2007 – National Academy of Sciences
Nuclear Medicine Holds Many Promises for Improved Care “Executive summary on the availability or lack thereof US medical isotope production…